News and Analysis
Innovation, Technology, and IP News
Patexia Insight 194: The Top Lateral Moves of PTAB Attorneys in 2023
The Patent Trial and Appeal Board (PTAB) holds a pivotal position within intellectual property law, wielding substantial influence over patent validity determinations and dispute...
The First FDA Approved, Chinese Developed, PD-1 Inhibitor For Nasopharyngeal Carcinoma
Written by: Jason J. Jardine On October 27th, 2023, the U.S. Food and Drug Administration (FDA) approved LOQTORZITM (toripalimab-tpzi), developed by Coherus BioSciences, Inc...
Tata Faces Trade Secrets Setback: $210M Damages in DXC Technology Case, Jury Says
Tata Consultancy Services (TCS), a prominent Indian software conglomerate, has recently been embroiled in a legal battle with DXC Technology, resulting in a substantial setback. A ...
FDA Issues Long-Overdue Regulations on Direct-To-Consumer Advertisements for Prescription Medications
Written by: Lucas P. Koziol, Ph.D. & Michael L. Fuller On November 21, 2023, the FDA published its final rule changing how prescriptions medicines are advertised to...
The legal battle between chipmaker Intel Corporation and patent holding company VLSI has taken another turn as the US Court of Appeals for ... Read More »
CASE OF THE WEEK
Penumbra, Inc. v. Rapidpulse, Inc., IPR2021-01466, Paper 34 (P.T.A.B. March 10, 2023)
In a PTAB decision... Read More »
Written by: Susan M. Janicki, Ph.D. & Agnes Juang, Ph.D.
The Federal Trade Commission (FTC) issued a policy statement[1] on... Read More »
Written by: Alexander D. Zeng & Philip M. Nelson
On October 5, 2023, the World Intellectual Property Organization... Read More »
The Patent Trial and Appeal Board (PTAB) holds a pivotal position within intellectual property law, wielding substantial influence over patent... Read More »
Written by: Jason J. Jardine
On October 27th, 2023, the U.S. Food and Drug Administration (FDA) approved LOQTORZITM... Read More »
Tata Consultancy Services (TCS), a prominent Indian software conglomerate, has recently been embroiled in a legal battle with DXC... Read More »
Written by: Lucas P. Koziol, Ph.D. & Michael L. Fuller
On November 21, 2023, the FDA published its final rule... Read More »
CASE OF THE WEEK
Purdue Pharma L.P. v. Collegium Pharmaceutical, Inc. (United States Patent and Trademark Office intervening), Appeal... Read More »
On November 15th, Lenovo (United States) Inc., a technology corporation, lodged a patent infringement complaint with the United States... Read More »
CASE OF THE WEEK
Medtronic, Inc. et al. v. Teleflex Life Sciences Ltd., Appeal Nos. 2022-1721, -1722 (Fed. Cir. Nov. 16, 2023)
... Read More »
The United States Patent and Trademark Office (USPTO) has recently introduced a significant update to its rules concerning patent... Read More »
In the dynamic realm of innovation, securing a patent isn't merely about claiming ownership; it's a strategic journey navigating through... Read More »
In a turn of events within the semiconductor industry, Chinese flash memory manufacturer Yangtze Memory Technologies Co (YMTC) has... Read More »
CASE OF THE WEEK
Allgenesis Biotherapeutics Inc. v. Cloudbreak Therapeutics, LLC, Appeal No. 2022-1706 (Fed. Cir. Nov. 7, 2023)
... Read More »
Written by: Brittany M. Penn
CooperCompanies announced on November 1, 2023, the purchase of Cook... Read More »
Written by: Brianne M. Kingery & Robert J. Hilton, Ph.D.
In a recent precedential opinion, the Court of Appeals for the Federal... Read More »
In a recent development, Amazon has been ordered by a jury in Delaware federal court to pay $46.7 million in damages for... Read More »
In August, our much-anticipated fourth annual ANDA Litigation Intelligence Report made its entrance into the world of pharmaceutical litigation... Read More »
Written by: Mengmeng Du
Neurovalens successfully secured 510(k) clearance from the FDA on October 27, 2023 for its Modius... Read More »
